We recommend to use Response Genetics fundamental analysis to find out if markets are presently mispricing the firm. Put it differently this technique allows you to confirm available drivers of Response Genetics as well as the relationship between them. We have analyzed and interpolated thirty available financial ratios for Response Genetics, which can be compared to its competitors. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Response Genetics to be traded at $1.0E-4 in 90 days.
Response
Response Genetics Stock Summary
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California. RESPONSE GENETICS operates under Diagnostics Research classification in the United States and is traded on PNK Exchange. It employs 96 people.
Response Genetics' financial ratios allow both analysts and investors to convert raw data from Response Genetics' financial statements into concise, actionable information that can be used to evaluate the performance of Response Genetics over time and compare it to other companies across industries.
Comparative valuation techniques use various fundamental indicators to help in determining Response Genetics's current stock value. Our valuation model uses many indicators to compare Response Genetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Response Genetics competition to find correlations between indicators driving Response Genetics's intrinsic value. More Info.
Response Genetics is currently regarded as top stock in return on asset category among its peers. It also is currently regarded as top stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Response Genetics' earnings, one of the primary drivers of an investment's value.
Additional Tools for Response Pink Sheet Analysis
When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.